SAN JOSE, Calif.--(BUSINESS WIRE)--Nov. 2, 2005--HemoSense, Inc. (AMEX:HEM) today announced that it has entered into definitive agreements to sell shares of its common stock at a price of $6.75 per share, raising approximately $10 million in gross proceeds from certain institutional investors. The transaction is expected to close on November 4, 2005 following the American Stock Exchange’s approval of HemoSense’s Application for Listing of Additional Shares. In connection with their participation in the closing, these investors will receive 50% warrant coverage at a price of $8.165 per share.
